You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors

Authors

  • Isobel Okoye School of Dentistry, Faculty of Medicine and Dentistrty, University of Alberta, Edmonton, AB, Canada PubMed articlesGoogle scholar articles
  • Lai Xu School of Dentistry, Faculty of Medicine and Dentistrty, University of Alberta, Edmonton, AB, Canada PubMed articlesGoogle scholar articles
  • Melika Motamedi Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada PubMed articlesGoogle scholar articles
  • Pallavi Parashar School of Dentistry, Faculty of Medicine and Dentistrty, University of Alberta, Edmonton, AB, Canada PubMed articlesGoogle scholar articles
  • John W Walker Medical Oncology, Cross Cancer Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada PubMed articlesGoogle scholar articles
  • Shokrollah Elahi School of Dentistry, Faculty of Medicine and Dentistrty, University of Alberta, Edmonton, AB, Canada Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada Medical Oncology, Cross Cancer Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada Li Ka Shing Institute of Virology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada PubMed articlesGoogle scholar articles

Citation

Okoye I, Xu L, Motamedi M, et al
Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors
Journal for ImmunoTherapy of Cancer 2020;8:e001849. doi: 10.1136/jitc-2020-001849
Online issue publication 
December 12, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.